188 related articles for article (PubMed ID: 28055982)
1. Preparation of multilocation reduction-sensitive core crosslinked folate-PEG-coated micelles for rapid release of doxorubicin and tariquidar to overcome drug resistance.
Yi X; Zhao D; Zhang Q; Xu J; Yuan G; Zhuo R; Li F
Nanotechnology; 2017 Feb; 28(8):085603. PubMed ID: 28055982
[TBL] [Abstract][Full Text] [Related]
2. Folate-Targeted Redox-Responsive Polymersomes Loaded with Chemotherapeutic Drugs and Tariquidar to Overcome Drug Resistance.
Qin Y; Zhang Z; Huang C; Fan F; Liu L; Lu L; Wang H; Liu Z; Yang J; Wang C; Yang H; Sun H; Leng X; Kong D; Zhang L; Zhu D
J Biomed Nanotechnol; 2018 Oct; 14(10):1705-1718. PubMed ID: 30041718
[TBL] [Abstract][Full Text] [Related]
3. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
5. Folate-conjugated amphiphilic block copolymer micelle for targeted and redox-responsive delivery of doxorubicin.
Lv Y; Yang B; Li YM; He F; Zhuo RX
J Biomater Sci Polym Ed; 2018 Jan; 29(1):92-106. PubMed ID: 29090629
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
Kim D; Lee ES; Park K; Kwon IC; Bae YH
Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
[TBL] [Abstract][Full Text] [Related]
7. Targeted H
Deng Z; Tang M; Zhao L; Long Y; Wen Z; Cheng Y; Zheng H
Colloids Surf B Biointerfaces; 2017 Dec; 160():207-214. PubMed ID: 28934664
[TBL] [Abstract][Full Text] [Related]
8. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
9. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
Xiong D; Zhang X; Peng S; Gu H; Zhang L
Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
11. A pH and redox dual stimuli-responsive poly(amino acid) derivative for controlled drug release.
Gong C; Shan M; Li B; Wu G
Colloids Surf B Biointerfaces; 2016 Oct; 146():396-405. PubMed ID: 27388968
[TBL] [Abstract][Full Text] [Related]
12. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells.
Luesakul U; Puthong S; Neamati N; Muangsin N
Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
[TBL] [Abstract][Full Text] [Related]
15. Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery.
Wang S; Wang H; Liu Z; Wang L; Wang X; Su L; Chang J
Nanoscale; 2014 Jul; 6(13):7635-42. PubMed ID: 24898341
[TBL] [Abstract][Full Text] [Related]
16. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.
Xu W; Han M; Diao Y; Pan T; Ge W; Liu H; He H; Jiang H; Zheng S; Zhang S; Gao J; Wei Q
Discov Med; 2014 Oct; 18(99):169-77. PubMed ID: 25336030
[TBL] [Abstract][Full Text] [Related]
19. Functionalized MoS
Zhang X; Wu J; Williams GR; Niu S; Qian Q; Zhu LM
Colloids Surf B Biointerfaces; 2019 Jan; 173():101-108. PubMed ID: 30273870
[TBL] [Abstract][Full Text] [Related]
20. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
